Millennium Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Millennium Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200,000	Closed	-$10.5M	–	4675
2019 Q2	$10.5M	Buy	+200,000	New	+$11.5M	0.02%	1202
2018 Q3	–	Sell	-80,000	Closed	-$3.62M	–	4405
2018 Q2	$3.62M	Buy	80,000 +30,000	+60%	+$1.37M	﹤0.01%	2019
2018 Q1	$2.42M	Buy	+50,000	New	+$2.79M	﹤0.01%	2202

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's GBT Position: Q4 2022 in Review

Millennium Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 543,632 shares — an estimated $37M sold.

Millennium Management first reported a position in GBT in Q3 2015 and held it in 24 quarters. The position peaked at $37M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Millennium Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 543,632 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $37M.
Millennium Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 24 quarters.
Millennium Management's Global Blood Therapeutics, Inc. position peaked at $37M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.